 | Zynerba Pharmaceuticals (NASDAQ:ZYNE) Stock Rating Reaffirmed by HC Wainwright
www.americanbankingnews.com - July 2 at 11:43 AM |
 | Zynerba's Zygel Fails in Phase III Fragile X Syndrome Study
www.nasdaq.com - July 1 at 2:21 PM |
 | Zynerba's Zygel Fails in Phase III Fragile X Syndrome Study
finance.yahoo.com - July 1 at 2:21 PM |
| Zynerba Pharmaceuticals (NASDAQ:ZYNE) Price Target Lowered to $8.00 at Cantor Fitzgerald
www.americanbankingnews.com - July 1 at 10:40 AM |
| Zynerba Pharmaceuticals (NASDAQ:ZYNE) Rating Lowered to Hold at Needham & Company LLC
www.americanbankingnews.com - July 1 at 10:40 AM |
| Canaccord Genuity Trims Zynerba Pharmaceuticals (NASDAQ:ZYNE) Target Price to $12.00
www.americanbankingnews.com - July 1 at 9:27 AM |
 | BRIEF-Zynerba Pharmaceuticals Announces Top Line Results From Pivotal Connect-FX Trial Of Zygel
www.reuters.com - June 30 at 11:38 PM |
 | Synthetic Cannabinoid Drug Maker Zynerba Plummets 50%
www.benzinga.com - June 30 at 8:32 PM |
 | Zynerba Cannabinoid Investors Must Now Refocus on Treating Autism
www.msn.com - June 30 at 6:38 PM |
 | Zynerba's Zygel flunks Fragile X study
seekingalpha.com - June 30 at 8:37 AM |
|
| Zynerba Pharma: Zygel Study Fails To Achieve Statistical Significance In Endpoints
www.nasdaq.com - June 30 at 8:37 AM |
| Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome
finance.yahoo.com - June 30 at 8:37 AM |
| Zynerba's cannabis-based drug for rare genetic disorder fails study
finance.yahoo.com - June 30 at 8:37 AM |
| Stock Traders Buy High Volume of Put Options on Zynerba Pharmaceuticals (NASDAQ:ZYNE)
www.americanbankingnews.com - June 30 at 6:58 AM |
| Stock Traders Purchase Large Volume of Call Options on Zynerba Pharmaceuticals (NASDAQ:ZYNE)
www.americanbankingnews.com - June 30 at 2:38 AM |
| Notable Monday Option Activity: ZYNE, RH, BBBY
www.nasdaq.com - June 29 at 6:02 PM |
| Zynerba Pharmaceuticals (NASDAQ:ZYNE) Earns "Buy" Rating from LADENBURG THALM/SH SH
www.americanbankingnews.com - June 29 at 9:30 AM |
| -$0.46 EPS Expected for Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) This Quarter
www.americanbankingnews.com - June 26 at 9:02 PM |
 | Zynerba Pharmaceuticals Inc
www.bloomberg.com - June 21 at 10:12 PM |
| Traders Purchase Large Volume of Put Options on Zynerba Pharmaceuticals (NASDAQ:ZYNE)
www.americanbankingnews.com - June 16 at 6:59 AM |
| Zynerba Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:ZYNE)
www.americanbankingnews.com - June 15 at 3:41 PM |
| Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - June 13 at 8:52 AM |
| Implied Volatility Surging for Zynerba Pharmaceuticals (ZYNE) Stock Options
www.nasdaq.com - May 28 at 12:49 PM |
| Zynerba's ZYN002 shows positive action in autism study
seekingalpha.com - May 27 at 11:46 AM |
| BRIEF-Zynerba Says Bright Trial Achieved Clinically Meaningful Improvements From Baseline
www.reuters.com - May 27 at 11:46 AM |
 | Main Line pharma company reports 'exciting step forward' with experimental autism treatment
www.bizjournals.com - May 27 at 11:46 AM |
| Zynerba Pharmaceuticals Announces Positive Top Line Results from Exploratory Open Label Phase 2 BRIGHT Trial of Zygel in Autism Spectrum Disorder
finance.yahoo.com - May 27 at 11:46 AM |
| BRIEF-Zynerba Pharmaceuticals Announces New Two-Year Data From Open Label Extension Of The Phase 2 Fab-C Trial In Patients With Fragile X
www.reuters.com - May 26 at 12:41 PM |
| Zynerba Pharmaceuticals Announces Presentation of Phase 2 BELIEVE Safety, Efficacy and Quality of Life Data in Developmental and Epileptic Encephalopathies (DEE) at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session
finance.yahoo.com - May 26 at 7:36 AM |
| Zynerba Pharmaceuticals Announces New Two-Year Data from Open Label Extension of the Phase 2 FAB-C Trial in Patients with Fragile X at 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session
finance.yahoo.com - May 26 at 7:36 AM |
|
| Zynerba Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 22 at 7:38 AM |
| Zynerba Pharmaceuticals Changes Annual Meeting of Shareholders to Virtual-Only Format in Response to COVID-19 Pandemic
finance.yahoo.com - May 21 at 12:46 PM |
| BRIEF-Zynerba Pharmaceuticals Reports First Quarter 2020 Results
www.reuters.com - May 11 at 9:22 PM |
| Zynerba up 23% ahead of key data readouts
seekingalpha.com - May 11 at 4:21 PM |
| Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights
finance.yahoo.com - May 11 at 8:33 AM |
| How Much is Zynerba Pharmaceuticals, Inc.'s (NASDAQ:ZYNE) CEO Getting Paid?
finance.yahoo.com - April 28 at 1:39 PM |
| INVESTOR ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action
www.bloomberg.com - April 24 at 5:48 PM |
| Medical CBD Company Zynerba Rallies On Q4 Report, CEO Says 2020 Outlook 'Promising'
www.benzinga.com - March 10 at 2:00 PM |
 | Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights
www.globenewswire.com - March 10 at 8:59 AM |
| Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights
finance.yahoo.com - March 10 at 8:59 AM |
| Zynerba Pharmaceuticals Announces Poster Presentations at the American Academy of Neurology (AAN) 2020 Annual Meeting
finance.yahoo.com - March 9 at 1:05 PM |
| Zynerba Pharmaceuticals to Present at the 32nd Annual ROTH Conference
finance.yahoo.com - March 5 at 11:42 AM |
| Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers
finance.yahoo.com - March 3 at 12:44 PM |
| Zynerba Pharmaceuticals Presents Data Showing that the Baseline Characteristics of Patients in Phase 2 BRIGHT Trial in Autism Spectrum Disorder Indicate a Moderate-to-Severe Study Population
finance.yahoo.com - March 3 at 12:44 PM |
| BRIEF-Zynerba Pharmaceuticals Announces The Completion Of Enrollment In The Pivotal Connect-FX Trial Of Zygel In Fragile X Syndrome
www.reuters.com - February 26 at 2:57 PM |
| Zynerba Pharmaceuticals Announces the Completion of Enrollment in the Pivotal CONNECT-FX Trial of Zygel™ in Fragile X Syndrome
finance.yahoo.com - February 26 at 8:03 AM |
| Zynerba Pharmaceuticals, Inc.'s (NASDAQ:ZYNE) Path To Profitability
finance.yahoo.com - February 25 at 2:10 PM |
| Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with Purified Cannabidiol
finance.yahoo.com - February 25 at 7:37 AM |
| Zynerba Pharmaceuticals Announces Presentations at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Annual Meeting
finance.yahoo.com - February 20 at 8:35 AM |
| Zynerba Pharmaceuticals (ZYNE) Gains But Lags Market: What You Should Know
finance.yahoo.com - February 10 at 7:26 PM |
